Morgan Stanley
ISEE

Morgan Stanley’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Morgan Stanley’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,791,906
Closed -$70.5M – 7841
2023
Q2 		$70.5M Buy
1,791,906
+960,943
+116% +$33.9M 0.01% 1307
2023
Q1 		$20.2M Buy
830,963
+398,083
+92% +$8.72M ﹤0.01% 2403
2022
Q4 		$9.27M Buy
432,880
+108,726
+34% +$2.32M ﹤0.01% 3163
2022
Q3 		$5.82M Sell
324,154
-535,051
-62% -$7.02M ﹤0.01% 3544
2022
Q2 		$8.27M Sell
859,205
-1,908,551
-69% -$24M ﹤0.01% 3268
2022
Q1 		$46.6M Buy
2,767,756
+2,157,122
+353% +$31.9M 0.01% 1348
2021
Q4 		$10.2M Sell
610,634
-310,557
-34% -$5.09M ﹤0.01% 2931
2021
Q3 		$15M Buy
921,191
+513,623
+126% +$5.59M ﹤0.01% 2409
2021
Q2 		$2.57M Buy
407,568
+378,856
+1,320% +$2.44M ﹤0.01% 4444
2021
Q1 		$177K Sell
28,712
-656,701
-96% -$3.99M ﹤0.01% 5725
2020
Q4 		$4.74M Buy
685,413
+649,375
+1,802% +$4.16M ﹤0.01% 3315
2020
Q3 		$203K Sell
36,038
-556,882
-94% -$2.66M ﹤0.01% 5112
2020
Q2 		$3.02M Buy
592,920
+281,609
+90% +$1.17M ﹤0.01% 3182
2020
Q1 		$1.07M Sell
311,311
-549,534
-64% -$3.21M ﹤0.01% 3901
2019
Q4 		$7.39M Buy
860,845
+106,687
+14% +$381K ﹤0.01% 2765
2019
Q3 		$845K Buy
754,158
+8,722
+1% +$10.1K ﹤0.01% 4398
2019
Q2 		$969K Sell
745,436
-225,194
-23% -$309K ﹤0.01% 4243
2019
Q1 		$1.37M Sell
970,630
-13,024
-1% -$18.2K ﹤0.01% 3891
2018
Q4 		$1.18M Buy
983,654
+31,620
+3% +$61.3K ﹤0.01% 4161
2018
Q3 		$2.25M Buy
952,034
+11,416
+1% +$28.5K ﹤0.01% 3914
2018
Q2 		$2.57M Buy
940,618
+298,487
+46% +$823K ﹤0.01% 3845
2018
Q1 		$1.76M Sell
642,131
-237,998
-27% -$690K ﹤0.01% 4121
2017
Q4 		$2.75M Buy
880,129
+837,803
+1,979% +$2.36M ﹤0.01% 3739
2017
Q3 		$120K Sell
42,326
-102,821
-71% -$278K ﹤0.01% 5527
2017
Q2 		$373K Sell
145,147
-2,084,004
-93% -$5.68M ﹤0.01% 4985
2017
Q1 		$8.16M Buy
2,229,151
+1,991,921
+840% +$8.42M ﹤0.01% 2405
2016
Q4 		$1.15M Sell
237,230
-144,009
-38% -$4.27M ﹤0.01% 4363
2016
Q3 		$17.6M Sell
381,239
-478,322
-56% -$27M 0.01% 1559
2016
Q2 		$43.9M Sell
859,561
-678,333
-44% -$33.7M 0.02% 866
2016
Q1 		$65M Buy
1,537,894
+1,073,505
+231% +$54.7M 0.03% 635
2015
Q4 		$36.5M Sell
464,389
-1,030,735
-69% -$59.6M 0.01% 980
2015
Q3 		$60.6M Buy
1,495,124
+65,957
+5% +$3.49M 0.02% 691
2015
Q2 		$74.4M Buy
1,429,167
+441,240
+45% +$22M 0.03% 650
2015
Q1 		$46M Buy
987,927
+200,082
+25% +$10.4M 0.02% 898
2014
Q4 		$35.3M Buy
787,845
+364,334
+86% +$15.3M 0.01% 1065
2014
Q3 		$16.5M Buy
423,511
+36,151
+9% +$1.42M 0.01% 1589
2014
Q2 		$16.4M Buy
387,360
+251,825
+186% +$9.24M 0.01% 1599
2014
Q1 		$4.83M Sell
135,535
-75,499
-36% -$2.55M ﹤0.01% 2606
2013
Q4 		$6.83M Buy
+211,034
New +$6.26M ﹤0.01% 2288

Morgan Stanley's ISEE Position: Q3 2023 in Review

Morgan Stanley sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,791,906 shares — an estimated $70.5M sold.

Morgan Stanley first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $74.4M in Q2 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Morgan Stanley reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 1,791,906 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $70.5M.
  • Morgan Stanley first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Morgan Stanley's IVERIC bio, Inc. Common Stock position peaked at $74.4M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.